Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · IEX Real-Time Price · USD
0.739
+0.009 (1.19%)
Jul 16, 2024, 10:55 AM EDT - Market open
1.19%
Market Cap 28.02M
Revenue (ttm) 11.32M
Net Income (ttm) -63.03M
Shares Out 38.13M
EPS (ttm) -1.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 91,936
Open 0.735
Previous Close 0.730
Day's Range 0.733 - 0.743
52-Week Range 0.710 - 1.560
Beta 0.93
Analysts Hold
Price Target 1.25 (+69.24%)
Earnings Date Aug 5, 2024

About BOLT

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company’s lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Feb 5, 2021
Employees 100
Stock Exchange NASDAQ
Ticker Symbol BOLT
Full Company Profile

Financial Performance

In 2023, BOLT's revenue was $7.88 million, an increase of 37.48% compared to the previous year's $5.73 million. Losses were -$69.20 million, -21.45% less than in 2022.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for BOLT stock is "Hold." The 12-month stock price forecast is $1.25, which is an increase of 69.24% from the latest price.

Price Target
$1.25
(69.24% upside)
Analyst Consensus: Hold
Stock Forecasts

News

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / July 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

1 hour ago - Accesswire

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit

NEW YORK , July 15, 2024 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021...

15 hours ago - PRNewsWire

BOLT Stockholders with Large Losses Should Contact Robbins LLP for Information About the Bolt Biotherapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)---- $BOLT #BoltBiotherapeuticsInc--Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Cand...

20 hours ago - Business Wire

BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ...

21 hours ago - GlobeNewsWire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 20...

21 hours ago - GlobeNewsWire

Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for Bolt Biotherapeutics, Inc. to Lead the Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

1 day ago - Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ:BOLT) and certain of...

1 day ago - Accesswire

A Shareholder alert for Bolt Biotherapeutics, Inc. was sent by Bronstein, Gewirtz and Grossman, LLC to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / July 14, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

2 days ago - Accesswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SeaStar and Bolt and Encourages Investors to Contact the Firm

NEW YORK, July 13, 2024 (GLOBE NEWSWIRE) --  Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of sto...

Other symbols: ICU
2 days ago - GlobeNewsWire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 20...

3 days ago - GlobeNewsWire

BOLT SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action

NEWTOWN, Pa. , July 12, 2024 /PRNewswire/ -- Edelson Lechtzin LLP, a leading class action law firm, reminds investors about the impending deadline to seek appointment as lead plaintiff in the securiti...

3 days ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BOLT

NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT) and certain o...

3 days ago - GlobeNewsWire

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Contact the Firm!

NEW YORK CITY, NY / ACCESSWIRE / July 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

4 days ago - Accesswire

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC - RECOGNIZED INVESTOR COUNSEL - Reminds Bolt Biotherapeutics, Inc. Shareholders to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

5 days ago - Accesswire

BOLT Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Bolt Biotherapeutics, Inc.

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Bolt Biotherap...

5 days ago - GlobeNewsWire

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bolt Biothe...

6 days ago - Accesswire

BOLT ALERT: Bragar Eagel & Squire, P.C. is Investigating Bolt Biotherapeutics, Inc. on Behalf of Bolt Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bolt Biotherapeutics, Inc. (“Bol...

6 days ago - GlobeNewsWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Bolt Biother...

7 days ago - GlobeNewsWire

Bolt Biotherapeutics, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the BOLT Class Action

SAN DIEGO--(BUSINESS WIRE)---- $BOLT #BOLT--Robbins LLP is Investigating Allegations that Bolt Therapeutics, Inc. (BOLT) Misled Investors Regarding the Viability of its New Drug Candidate.

8 days ago - Business Wire

Bolt Biotherapeutics, Inc. Sued for Securities Law Violations - Contact The Rosen Law Firm Before September 3, 2024 to Discuss Your Rights - BOLT

NEW YORK , July 6, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Bolt Biotherapeu...

9 days ago - PRNewsWire

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK, July 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Bolt Biother...

10 days ago - GlobeNewsWire

Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against Bolt Biotherapeutics, Inc. (BOLT)

SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Bolt Biotherap...

12 days ago - GlobeNewsWire

ROSEN, A TOP RANKED LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK--(BUSINESS WIRE)---- $BOLT #BOLT--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Bolt Biothera...

12 days ago - Business Wire

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of C...

12 days ago - GlobeNewsWire

Class Action Lawsuit Filed on Behalf of Bolt Biotherapeutics, Inc. (BOLT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, July 03, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against officers of Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT). The lawsuit allege...

12 days ago - GlobeNewsWire